Evidence map›Paper›PMID 35106030›Full record

ArticleDer Onkologe : Organ der Deutschen Krebsgesellschaft e.V2022

[Nearly two years of the coronavirus pandemic from the perspective of people affected by cancer].

Andrea Gaisser, Rachel D Eckford, Volker Arndt, Daniela Doege, Evelyn Kludt, Jasper Ubels, Michael Schlander, Susanne Weg-Remers

Abstract read
In one paragraph

Article in Der Onkologe : Organ der Deutschen Krebsgesellschaft e.V, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Impact of the COVID-19 pandemic on training conditions and education in oncologic disciplines: a survey-based analysis.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrea GaisserKrebsinformationsdienst, Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Deutschland.
Rachel D EckfordAbteilung für Gesundheitsökonomie, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Deutschland.
Volker ArndtArbeitsgruppe Cancer Survivorship, Abteilung für Klinische Epidemiologie und Alternsforschung, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Deutschland.
Daniela DoegeArbeitsgruppe Cancer Survivorship, Abteilung für Klinische Epidemiologie und Alternsforschung, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Deutschland.
Evelyn KludtKrebsinformationsdienst, Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Deutschland.
Jasper UbelsAbteilung für Gesundheitsökonomie, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Deutschland.
Michael SchlanderAbteilung für Gesundheitsökonomie, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Deutschland.
Susanne Weg-RemersKrebsinformationsdienst, Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35106030
PMCPMC8796180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.